Late-stage clinical biopharmaceutical company developing novel cancer immunotherapies like galinpepimut-S and SLS009.[1][3]
Get notified the moment SELLAS Life Sciences Group, Inc. (SLS) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.